2-(2,6-dioxopiperidin-3-yl)phthalimidine has been researched along with supidimide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eger, K; Figg, WD; Gütschow, M; Hauschildt, S; Hecker, TK; Lepper, ER; Luzzio, FA; Ng, SS; Weiss, M | 1 |
| Nicolai, S; Sies, H; Stahl, W | 1 |
| Banquerigo, ML; Brahn, E; Cheng, TP; Oliver, SJ | 1 |
3 other study(ies) available for 2-(2,6-dioxopiperidin-3-yl)phthalimidine and supidimide
| Article | Year |
|---|---|
Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors.
Topics: Angiogenesis Inhibitors; Animals; Aorta, Thoracic; In Vitro Techniques; Male; Microcirculation; Models, Molecular; Molecular Conformation; Muscle, Smooth, Vascular; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Thalidomide | 2004 |
Stimulation of gap junctional intercellular communication by thalidomide and thalidomide analogs in human skin fibroblasts.
Topics: Cell Communication; Cell Line; Fibroblasts; Gap Junctions; Humans; Skin; Stereoisomerism; Thalidomide | 1997 |
The effect of thalidomide and 2 analogs on collagen induced arthritis.
Topics: Animals; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Endothelial Growth Factors; Female; Immunosuppressive Agents; Lymphokines; Radiography; Rats; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |